Ernexa Therapeutics Warrants (ERNAW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 109 141 sessions, February 6, 2026 to October 21, 2026
- Largest daily move
- +128.3% close of July 6, 2026
- 1-month change
- -20.3% closing prices, September 21, 2026 to October 21, 2026
Company Description
Ernexa Therapeutics Warrants (NASDAQ: ERNAW) is classified in the pharmaceutical preparations industry.
ERNAW has declined 20.3% over the past month. The last closing price was $0.0251.
For FY2025, Ernexa Therapeutics Warrants reported net income of -$14.1M and diluted earnings per share of -$2.24.
This page collects what Stock Titan holds for ERNAW, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Ernexa Therapeutics Warrants (ERNAW) closed at $0.0251 on October 21, 2026. Over the past month, the price has lost 20.3%.
ERNAW Metrics & Rankings
Price returns through October 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Ernexa Therapeutics Warrants has filed 10 recent SEC filings, including 5 Form 4, 3 Form 8-K, 1 Form 3, 1 Form 10-Q. The most recent filing was submitted on October 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ERNAW SEC filings →
Financial Highlights
operating income reached -$9.3M, and net income was -$14.1M. Diluted earnings per share stood at -$2.24. The company generated -$7.0M in operating cash flow. The current ratio was 1.01, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Ernexa Therapeutics Warrants (ERNAW) currently stands at 2.0 thousand shares, up 4.8% from the previous reporting period. Since February 2026, short interest has increased by 883.5%.
Days to Cover History
Days to cover for Ernexa Therapeutics Warrants (ERNAW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
ERNAW Company Profile & Sector Positioning
Ernexa Therapeutics Warrants (ERNAW) and is listed on the NASDAQ.